Denali Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$891K Sell
1,502
-200
-12% -$99.6K 0.1% 192
2025
Q4
$829K Sell
1,702
-201
-11% -$93.6K 0.09% 204
2025
Q3
$798K Buy
1,903
+703
+59% +$236K 0.09% 184
2025
Q2
$345K Sell
1,200
-303
-20% -$90.6K 0.04% 267
2025
Q1
$463K Buy
1,503
+100
+7% +$34.3K 0.05% 239
2024
Q4
$495K Buy
+1,403
New +$516K 0.05% 236
2021
Q3
Sell
-200
Closed -$36K 325
2021
Q2
$36K Buy
200
+100
+100% +$19K 0.01% 188
2021
Q1
$17K Sell
100
-3,400
-97% -$567K 0.01% 293
2020
Q4
$531K Sell
3,500
-800
-19% -$105K 0.09% 200
2020
Q3
$434K Sell
4,300
-2,400
-36% -$263K 0.09% 211
2020
Q2
$811K Buy
+6,700
New +$754K 0.16% 161
2019
Q4
Sell
-9,600
Closed -$766K 354
2019
Q3
$766K Sell
9,600
-76,900
-89% -$6.19M 0.11% 168
2019
Q2
$6.75M Buy
86,500
+20,900
+32% +$1.95M 1.01% 41
2019
Q1
$7.7M Sell
65,600
-27,400
-29% -$3.19M 1.23% 35
2018
Q4
$10.1M Buy
+93,000
New +$10.8M 1.69% 26

Other funds holding UTHR